Showing results (211-220 of 219) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 219 results.
Bioorganic Chemistry|November 12, 2023
Discovery of a potent and selective PARP1 degrader promoting cell cycle arrest via intercepting CDC25C-CDK1 axis for treating triple-negative breast cancerYiquan Wu, Mingfei Wu, Xiaoli Zheng, et al.
Radiation Oncology (London, England)|January 23, 2024
A PET/CT radiomics model for predicting distant metastasis in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy: a multicentric studyLu Yu, Zhen Zhang, HeQing Yi, et al.
Frontiers in Oncology|August 1, 2022
Genomic Profiling Reveals Novel Predictive Biomarkers for Chemo-Radiotherapy Efficacy and Thoracic Toxicity in Non-Small-Cell Lung CancerKewen He, Shaotong Zhang, Jiaohui Pang, et al.
Signal Transduction and Targeted Therapy|September 5, 2020
An individualized immune signature of pretreatment biopsies predicts pathological complete response to neoadjuvant chemoradiotherapy and outcomes in patients with esophageal squamous cell carcinomaChaoqi Zhang, Guochao Zhang, Nan Sun, et al.
ACS Applied Materials & Interfaces|March 8, 2017
Electric-Field Modulation of Interface Magnetic Anisotropy and Spin Reorientation Transition in (Co/Pt)<sub>3</sub>/PMN-PT HeterostructureYing Sun, You Ba, Aitian Chen, et al.
International Journal of Radiation Oncology, Biology, Physics|December 23, 2021
Comprehensive Next-Generation Sequencing Reveals Novel Predictive Biomarkers of Recurrence and Thoracic Toxicity Risks After Chemoradiation Therapy in Limited Stage Small Cell Lung CancerLi Li, Shanshan Tang, Jiani C Yin, et al.
Cancer Letters|June 12, 2025
Identification of an Individualized Immune-Related miRNA Pair Signature for Survival Prediction of Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell CancerPeng Wu, Dexin Shang, Li Liu, et al.
Clinical and Translational Medicine|September 8, 2020
A three-lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapyChaoqi Zhang, Zhihui Zhang, Guochao Zhang, et al.
BMC Cancer|March 8, 2024
Consolidation chemotherapy after definitive concurrent chemoradiotherapy in patients with inoperable esophageal squamous cell carcinoma: a multicenter non-inferiority phase III randomized clinical trialChengcheng Fan, Xu Wang, Xiaoli Zheng, et al.
Pageof 22